In today’s healthcare landscape, personalization isn’t a luxury—it’s a necessity. In his latest article for Med Ad News, Hari Ramachandran, Executive Vice President, Direct-to-Patient Product Management at EVERSANA, explores how Artificial Intelligence is transforming Direct-to-Patient (DTP) programs from simple delivery services into deeply personalized care experiences.
The article showcases how smart technology is helping patients feel seen, supported and safe. With Affinity models that adapt tone, timing and channel preferences, pharma brands can now communicate in ways that truly resonate.
But personalization must be built on trust. In order to ensure that innovation never compromises patient protection, we must emphasize the importance of data privacy, HIPAA compliance and ethical safeguards.
Read the full article here.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…